Cargando…
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
SARS-CoV-2-neutralizing antibodies (NAbs) protect against COVID-19. A concern regarding SARS-CoV-2 antibodies is whether they mediate disease enhancement. Here, we isolated NAbs against the receptor-binding domain (RBD) or the N-terminal domain (NTD) of SARS-CoV-2 spike from individuals with acute o...
Ejemplares similares
-
Cold sensitivity of the SARS-CoV-2 spike ectodomain
por: Edwards, Robert J, et al.
Publicado: (2021) -
Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates
por: McCarthy, Kevin R., et al.
Publicado: (2021) -
Structural diversity of the SARS-CoV-2 Omicron spike
por: Gobeil, Sophie M.-C., et al.
Publicado: (2022) -
Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
por: Stalls, Victoria, et al.
Publicado: (2022) -
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
por: Gobeil, Sophie M.-C., et al.
Publicado: (2021)